Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hereditary bone tumors].

D Baumhoer1

  • 1Institut für Pathologie, Knochentumor-Referenzzentrum, Universitätsspital Basel, Schönbeinstrasse 40, 4031, Basel, Schweiz. daniel.baumhoer@usb.ch.

Der Pathologe
|April 20, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.

ESMO open·2024
Same author

Recent advances in molecular profiling of bone and soft tissue tumors.

Skeletal radiology·2024
Same author

Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.

The Journal of bone and joint surgery. American volume·2020
Same author

Quantitative signal intensity ratios to distinguish between subfascial lipoma and atypical lipomatous tumor/well-differentiated liposarcoma using short-tau inversion recovery (STIR) MRI.

Diagnostic and interventional imaging·2020
Same author

The Mutational Profile of Unicystic Ameloblastoma.

Journal of dental research·2018
Same author

[Cystic lesions of the jaws].

Der Pathologe·2018
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Hereditary bone tumors arise from genetic mutations affecting cell cycle, metabolism, signaling, or DNA integrity. These rare conditions can lead to benign or malignant bone tumors, differing from sporadic tumors in presentation.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Hereditary bone tumors are rare genetic disorders.
  • Mutations impact cell cycle, metabolism, signaling, and DNA integrity.
  • Syndromes include retinoblastoma, Li-Fraumeni, Gardner, enchondromatosis, and multiple hereditary exostoses.

Purpose of the Study:

  • To review the genetic basis of hereditary bone tumors.
  • To discuss the spectrum of tumors associated with these syndromes.
  • To highlight differences between hereditary and sporadic bone tumors.

Main Methods:

  • Literature review of genetic mutations and associated syndromes.
  • Analysis of tumor types, transformation potential, and clinical presentation.
  • Comparison of hereditary vs. sporadic tumor characteristics.
Keywords:
EnchondromatosisGardner syndromeLi-Fraumeni syndromeRetinoblastoma syndromeRothmund-Thomson syndromeWerner syndrome

Related Experiment Videos

Main Results:

  • Hereditary bone tumors result from mutations in genes regulating cell cycle (RB1, TP53), metabolism (IDH1/2), signaling (EXT1/2), and DNA integrity (RECQL4, WRN, BLM).
  • Syndromes can cause benign tumors (enchondromas, osteochondromas, osteomas) that may transform malignantly or lead to bone sarcomas (osteosarcomas).
  • Syndrome-related neoplasms often differ from sporadic tumors in age of onset, location, and histology.

Conclusions:

  • Understanding the genetic underpinnings of hereditary bone tumors is crucial.
  • Recognition of specific tumor characteristics aids in identifying predisposition syndromes.
  • Further research is needed to fully elucidate the mechanisms of these rare conditions.